RecruitingNot ApplicableNCT07158970

Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)

Effect of Home Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus

Sponsor

Wolfson Medical Center

Enrollment

90 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

Gestational Diabetes Mellitus

Summary

This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 51 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Use of the Pulsenmore home ultrasound device for fetal assessment, guided remotely by a physician. for people with gestational diabetes mellitus. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 51 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.